Course Description:

It is estimated that 35-45% of the 3.1 million breast cancer survivors in the US will develop treatment-related lymphedema. New diagnostic imaging and research on treatment techniques have given fresh insight into the possible factors that contribute to the edema process as well as the effective application of treatment options. The concept of “transient” vs. “persistent” edema will be introduced, including how etiology might impact treatment choices. Normal tissue microcirculation will be discussed as well as the pathophysiology of post-operative swelling. The most recent evidence on treatment techniques for breast cancer-related edema, including outcomes will be presented.